There is scarce information on AIDS-related cytomegalovirus (CMV) retinitis in middle-income countries. The objectives of this study were to identify the prevalence of active CMV retinitis in severely immunosuppressed people living with HIV (PLWHIV) and to describe its main features.
Methods
This retrospective cohort study was carried out at a tertiary center in São Paulo, Brazil. We included hospitalized adults PLWHIV with CD4 count ≤100 cells/μL, ≥ one quantitation of CMV DNA in plasma, and indirect ophthalmoscopy evaluation.
Results
Thirty-eight (21.6%) of 176 participants had at least an ophthalmoscopy diagnosis and only 3 (1.7%) individuals presented active CMV retinitis. All these participants were male, and retinitis was asymptomatic in 2 cases. Two participants had extraocular end-organ CMV disease and detectable CMV DNA in plasma.
Conclusions
These results show a low prevalence of active CMV retinitis in the evaluated population. However, 2 of 3 participants had asymptomatic active CMV retinitis and a fifth of participants had at least one ophthalmoscopy diagnosis, suggesting the need for routine ophthalmologic evaluation in hospitalized severely immunosuppressed PLWHIV. The profile of participants with active CMV retinitis was similar to that described in the pre-ART era and quantitation of CMV DNA in plasma was variable.
JabsDA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol2011; 151(2): 198–216.
2.
HeidenDFordNWilsonD, et al.Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. Plos Med2007; 4(12): 1845–1852.
3.
JabsDAVan NattaMLKempenJH, et al.Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol2002; 133(1): 48–61.
4.
LiuYChenASKamphaengkhamS, et al.Diagnostic utility of ocular symptoms and vision for cytomegalovirus retinitis. PLoS One2016; 11(10): e0165564.
5.
HolbrookJTJabsDAWeinbergDV, et al.Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol2003; 121(1): 99–107.
6.
YustIFoxZBurkeM, et al.Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001. Eur J Clin Microbiol Infect Dis2004; 23(7): 550–559.
7.
DeaytonJRWilsonPSabinCA, et al.Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS2000; 14(9): 1163–1170.
8.
SchwarczLChenMJVittinghoffE, et al.Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS2013; 27(4): 597–605.
9.
ColbyDJVoDQTeohSC, et al.Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam. Int J STD AIDS2014; 25(7): 516–522.
10.
von ElmEAltmanDGEggerM, et al.The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet2007; 370(2596): 1453–1457.
11.
HollandGNGottliebMSYeeRD, et al.Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol1982; 93(4): 393–402.
12.
Centers for Disease Control (CDC). Pneumocystis Pneumonia--Los Angeles [internet]. MMWR Morb Mortal Wkly Rep1981.
13.
Centers for Disease Control (CDC). Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections [internet]. MMWR Morb Mortal Wkly Rep1986.
14.
GallantJEMooreRDRichmanDD, et al.Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis1992; 166(6): 1223–1227.
15.
JabsDAGreenWRFoxR, et al.Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology1989; 96(7): 1092–1099.
16.
HollandGNVaudauxJDJengSM, et al.UCLA CMV Retinitis Study Group. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol2008; 145(1): 5–11.
17.
HollandGNVaudauxJDJengSM, et al.Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol2008; 145(1): 5–11.
18.
JabsDAVan NattaMLHolbrookJT, et al.Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology2007; 114(4): 780–786.
19.
SugarEAJabsDAAhujaA, et al.Studies of the ocular complications of AIDS research group. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol2012; 153(6): 1016–1024.
20.
FordNShubberZSaranchukP, et al.Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis2013; 57(9): 1351–1361.
21.
ArrudaRFMuccioliCBelfortJR. Achados Achados Oftalmológicos em Infectados Pelo HIV na Era Pós-Haart e Comparação Com Série de Pacientes Acientes Avaliados Aliados no Período Pré-Haart. Rev Assoc Med Bras2004; 50(2): 148–152.
22.
MatosKTFSantosMCMMuccioliC. Manifestações oculares do paciente infectado pelo HIV atendido no Departamento de Oftalmologia da Universidade Federal de São Paulo. Rev Assoc Med Bras1999; 45(4): 323–326.
23.
GharaiSVenkateshPGargS, et al.Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol2008; 15(4): 264–271.
24.
PathaiSGilbertCWeissHA, et al.Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa. Trop Med Int Health2011; 16(3): 356–359.
25.
JaffarSAriyoshiKFrithP, et al.Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in The Gambia, west Africa. Trop Med Int Health1999; 4(7): 487–492.
26.
KestelynP. The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm1999; 7(3–4): 173–177.
27.
TellesJPFernandesRBarrosTD, et al.Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil. HIV Res Clin Pract2021; 22(4): 87–95.
28.
JirawisonCYenMLeenasirimakulP, et al.Telemedicine screening for cytomegalovirus retinitis at the point of care for human immunodeficiency virus infection. JAMA Ophthalmol2015; 133(2): 198–205.
29.
TangYSunJHeT, et al.Clinical features of cytomegalovirus retinitis in HIV infected patients. Front Cel Infect Microbiol2020; 10: 136.
30.
SezginEJabsDAHendricksonSL, et al.Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis2010; 202(4): 606–613.
31.
SezginEvan NattaMLAhujaA, et al.Studies of the ocular complications of AIDS research group. Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol2011; 151(6): 999–1006.
32.
HooverDRPengYSaahA, et al.Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol1996; 114(7): 821–827.
33.
JabsDAAhujaAVan NattaM, et al.Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology2010; 117(11): 2152–2161.
34.
de JongMDGalassoGJGazzardB, et al.Summary of the II international symposium on cytomegalovirus. Antivir Res1998; 39(3): 141–162.
35.
JabsDAMartinBKFormanMS, et al.Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis2005; 192(4): 640–649.
